Talis Biomedical Corporation (NASDAQ:TLIS) Q2 2023 Earnings Call Transcript August 10, 2023
Talis Biomedical Corporation misses on earnings expectations. Reported EPS is $-8.27 EPS, expectations were $-0.73.
Operator: Good day and thank you for standing by. Welcome to the Talis Biomedical Second Quarter Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator...
